The Spanish biopharmaceutical company expands its catalog of bioreagents with more than 100,000 new references thanks to the new international distribution agreement signed with Antibody Research Corporation.
Abyntek Biopharma, the Spanish based company leader in the design and distribution of bioreagents for scientific research, reaches a new international distribution agreement with the United States biotech company: Antibody Research Corporation. Thanks to the agreement, Abyntek add more tan 100.000 new references to the catalogue, which is already exceeding 7 million units.
Antibody Research Corporation arrives to Spain thanks to Abyntek Biopharma. Manufacturing bioreagents since 2005, in the catalogue are offering antibodies, proteins and ELISA kits.